histafen
douglas pharmaceuticals limited - chlorphenamine maleate 0.4 mg/ml; chlorphenamine maleate 0.4 mg/ml - elixir - 2mg/5ml - active: chlorphenamine maleate 0.4 mg/ml excipient: amaranth ethanol nipastat propylene glycol purified water raspberry flavour 117668 saccharin sodium sodium cyclamate sorbitol as sorbitol solution 70% vanillin active: chlorphenamine maleate 0.4 mg/ml excipient: amaranth ethanol nipastat propylene glycol purified water raspberry flavour c3056 saccharin sodium sodium cyclamate sorbitol as sorbitol solution 70% vanillin
mydrilate 0.5% w/v eye drops
esteve pharmaceuticals gmbh - cyclopentolate hydrochloride - eye drops, solution - 0.5 percent weight/volume - anticholinergics; cyclopentolate
mydrilate 1.0% w/v eye drops
esteve pharmaceuticals gmbh - cyclopentolate hydrochloride - eye drops, solution - 1.0 percent weight/volume - anticholinergics; cyclopentolate
xylocaine 1% with adrenaline 1:100,000
pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline; ; lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous; adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline; lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous - solution for injection - active: adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection active: adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment nitrogen as nitrogen for injection sodium chloride sodium hydroxide as 2m solution for ph adjustment sodium metabisulfite water for injection
xylocaine 1% with adrenaline 1:200,000
pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.0091 mg/ml equivalent to 5 µg/ml adrenaline; ; lidocaine hydrochloride 10 mg/ml; adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]); lidocaine hydrochloride 10 mg/ml; adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]); lidocaine hydrochloride 10 mg/ml - solution for injection - active: adrenaline acid tartrate 0.0091 mg/ml equivalent to 5 µg/ml adrenaline lidocaine hydrochloride 10 mg/ml excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]) lidocaine hydrochloride 10 mg/ml excipient: carbon dioxide hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml ([=5mcg/ml adrenaline]) lidocaine hydrochloride 10 mg/ml excipient: carbon dioxide hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: · local infiltration · minor or major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia
xylocaine 2% with adrenaline 1:200,000
pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.0091 mg/ml; ; lidocaine hydrochloride 20 mg/ml; adrenaline acid tartrate 0.0091 mg/ml; lidocaine hydrochloride 20 mg/ml - solution for injection - active: adrenaline acid tartrate 0.0091 mg/ml lidocaine hydrochloride 20 mg/ml excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 0.0091 mg/ml lidocaine hydrochloride 20 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: · local infiltration · minor or major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia
co mycophenolate tablet
cobalt pharmaceuticals company - mycophenolate mofetil - tablet - 500mg - mycophenolate mofetil 500mg - immunosuppressive agents
histafen
douglas pharmaceuticals limited - chlorphenamine maleate 12mg equivalent to active pellets of 60-70 mg/g potency - modified release capsule - 12 mg - active: chlorphenamine maleate 12mg equivalent to active pellets of 60-70 mg/g potency excipient: gelatin maize starch purified talc shellac sucrose sugar spheres
histafen
douglas pharmaceuticals limited - chlorphenamine maleate 8mg equivalent to active pellets of 43-53 mg/g potency - modified release capsule - 8 mg - active: chlorphenamine maleate 8mg equivalent to active pellets of 43-53 mg/g potency excipient: gelatin maize starch purified talc shellac sucrose sugar spheres
stauffer chemicals trithion super oil
stauffer c/o ici australia operations p/l - carbophenothion - insecticide